1Ruffolo RR,Brooks DP.Carvedilol:A hovel cardiovascular drug with multiple actions.Cardiovasc Drug Rev,1992,10(2):127-157
2Strein K,Sponer G,Meuller-Beckmann B,et al.Pharmacological profile of carvedilol,a compound with beta-blocking and vasodilating properties.J Cardiovasc Pharmacol,1987,10(Suppl 11):33-41
3Packer M,Brigde MR,Cohn JN,et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.N Engl J Med,1996,334:1349-1355
4Bristow MR.Multi-center oral carvedilol heart failures assessment(MOCHA):A sixmonth dose-response evaluation in class Ⅱ～Ⅳ patients.Circulation,1995,92(1):1-14
5Feuerstein GZ,Yue TL,Cheng HY,et al.Myocardial protection by the novel vascodilating beta-blocker,carvedilol:potential revelance of anti-oxidant activity.J Hypertens,1993,11(4):41-48
6Yue TL,Mc Kenna PJ,Gu JL,et al.Carvedilol,a new vasodilating β-adrenoreceptor blocker antihypertensive drug,protects endothelial cells from damage initiated by xanthine oxidase and neutrophils.Cardiovase Res,1994,28(3):400-406
